Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases.

[1]  H. Mouridsen,et al.  Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. , 1984, European journal of cancer & clinical oncology.

[2]  F. Oesch,et al.  Isolation of a high spin form of cytochrome P-450 induced in rat liver by 3-methylcholanthrene. , 1983, Biochemical and biophysical research communications.

[3]  R. Morgenstern,et al.  Activation of microsomal glutathione S-transferase activity by sulfhydryl reagents. , 1979, Biochemical and biophysical research communications.

[4]  F. Oesch,et al.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  D. Alberts,et al.  Disposition of mitoxantrone in patients. , 1983, Cancer treatment reviews.

[6]  R. Novak,et al.  Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines. , 1983, Archives of biochemistry and biophysics.

[7]  I. Smith,et al.  Mitoxantrone (novantrone): a review of experimental and early clinical studies. , 1983, Cancer treatment reviews.

[8]  D. Nebert,et al.  Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. , 1985, Science.

[9]  R. Novak,et al.  Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation. , 1983, The Journal of pharmacology and experimental therapeutics.

[10]  E. Lock,et al.  Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity. , 1984, The Journal of pharmacology and experimental therapeutics.